MOLLY O'NEAL: Open Payments
NPI 1720115421 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$180 in 11 payments from 9 companies in 2025. Trend: 2023 $138 · 2024 $219 · 2025 $180
Food & beverage: $180
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 2 | $34 |
| ABBVIE INC. | 2 | $29 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $18 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: PREVNAR 20, FANAPT, MOUNJARO, TRELEGY ELLIPTA, BREZTRI, CAPLYTA, Cologuard Collection Kit, QULIPTA.
Industry payments across KY — which companies pay providers there.
